Tifluadom is primarily used in scientific research as a selective kappa opioid receptor agonist. It helps in studying the physiological and behavioral effects mediated by the kappa opioid system, such as pain modulation, mood regulation, and drug-seeking behavior. Due to its high selectivity, it is valuable in neuropharmacological studies aiming to understand opioid receptor function without significant interaction with other receptor types. It is not used clinically and is not approved for therapeutic use, remaining strictly a research compound in experimental settings.